The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer
- 27 August 2008
- journal article
- review article
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 21 (6) , 371-377
Abstract
The optimal management of newly diagnosed prostate cancer requires individualization of the treatment plan based upon the most accurate clinical characterization of tumor location and extent of disease. The role of imaging in prostate cancer staging continues to evolve. In this review, we address the utility of endorectal coil magnetic resonance imaging (eMRI) in both local staging and its ability to facilitate the decision in choosing one treatment strategy over another after the initial diagnosis of localized prostate cancer. Using the PubMed database and reference lists of key articles, we identified studies addressing the use of eMRI in tumor characterization and risk stratification in patients undergoing treatment for clinically localized prostate cancer. The findings identified within 54 selected studies were incorporated into a summary discussing the current limitations in cancer staging and the role eMRI plays in both the preoperative assessment and clinical decision-making in an attempt to improve our ability to individualize management approaches and tailor treatment. eMRI allows for more accurate local staging by complementing the existing clinical variables through improvements in spatial characterization of the prostatic zonal anatomy and molecular changes. These improvements in tumor staging enhance our ability to individualize treatment selection and tailor the approach to maximize cancer control while minimizing treatment related morbidity.Keywords
This publication has 58 references indexed in Scilit:
- Upgrading and Downgrading of Prostate Needle Biopsy Specimens: Risk Factors and Clinical ImplicationsUrology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on OutcomeJournal of Urology, 2006
- Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical ProstatectomyJNCI: Journal of the National Cancer Institute, 2006
- MORBIDITY AND FUNCTIONAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPYJournal of Urology, 2004
- The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomyCancer, 2004
- Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: Predictive value of serum chromogranin AThe Prostate, 2003
- PERCENT PROSTATE NEEDLE BIOPSY TISSUE WITH CANCER IS MORE PREDICTIVE OF BIOCHEMICAL FAILURE OR ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGEN OR GLEASON SCOREJournal of Urology, 2002
- Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigenWorld Journal of Urology, 1997
- Zonal Distribution of Prostatic AdenocarcinomaAmerican Journal of Surgical Pathology, 1988